Clin2
NCT06377696Possibly a fitRecruiting

Metformin study for brain tumor survivors after radiation

Malignant Brain Neoplasm

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This study tests whether metformin, a common diabetes medicine, can help protect thinking and memory skills in people who have had radiation for a brain tumor. You will use a smartwatch and take online tests from home to track your progress.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older.
  • You have had radiation therapy for a brain tumor, either during treatment or within the past 5 years.
  • You are able to take care of yourself and are expected to live at least 6 more months.
  • You can swallow pills and do not have severe liver problems.
  • You are willing to stop certain supplements like resveratrol, CoQ10, coconut oil, or curcumin for the study.
  • You can read and speak English well enough to complete the assessments.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05230758Recruiting· Phase 3
Metformin trial for brain tumor survivors’ brain and behavior

This Phase 3 study tests whether metformin can improve brain function, behavior, and thinking in children and teens who were treated for certain brain tumors. You may be able to join if you meet age, time-since-treatment, language, and health/lab safety requirements.

New Lambton Heights, New South Wales
NCT03184038Recruiting
Testing brain function in people with brain metastases after radiosurgery

This study looks at how well your thinking and memory work after treatment with radiosurgery for brain metastases. It may help researchers understand which patients benefit best and how to monitor side effects on brain function.

Sewell, New Jersey
NCT04945148Recruiting· Phase 2
Metformin plus radiation and chemo for glioblastoma subtype

This Phase 2 study tests whether adding metformin to standard radiation and temozolomide (chemo) can improve outcomes for people with newly diagnosed glioblastoma of a specific metabolic subtype. It aims to see if this combination is safer and more effective than standard treatment alone.

Suresnes, Hauts de Seine
NCT06594172Not yet recruiting· Phase 2
Medications to protect thinking after brain radiation

This trial tests whether starting two medicines early can help protect your memory and thinking abilities after whole-brain radiation for cancer that has spread to the brain. You would take memantine and pioglitazone while undergoing standard radiation treatment.

NCT07226466Not yet recruiting
Cognitive function study in brain cancer patients

This study looks at how cancer and its treatment affect thinking and memory. It may help find ways to protect brain function during radiotherapy.

San Francisco, California
NCT05929495Recruiting· Phase 2
Metformin added to standard treatment for newly diagnosed glioblastoma

This Phase 2 study tests whether adding metformin to the usual treatment for newly diagnosed glioblastoma (GBM) can improve outcomes. It involves taking metformin after surgery along with standard care (the Stupp protocol).

Milan

Hear when a new Malignant Brain Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.